help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on July 31, 2003, doi:10.1164/rccm.200212-1520OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200212-1520OCv1
168/10/1174    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Kluijver, J.
Right arrow Articles by Sterk, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Kluijver, J.
Right arrow Articles by Sterk, P. J.
American Journal of Respiratory and Critical Care Medicine Vol 168. pp. 1174-1180, (2003)
© 2003 American Thoracic Society

Are Rhinovirus-induced Airway Responses in Asthma Aggravated by Chronic Allergen Exposure?

Josephine de Kluijver, Christine E. Evertse, Jacob K. Sont, Jasmijn A. Schrumpf, Christel J. G. van Zeijl-van der Ham, Claire R. Dick, Klaus F. Rabe, Pieter S. Hiemstra and Peter J. Sterk

Departments of Pulmonology, Medical Decision Making, and Virology, Leiden University Medical Center, Leiden, The Netherlands; and Respiratory Virus Research Laboratory, University of Wisconsin, Madison, Wisconsin

Correspondence and requests for reprints should be addressed to Peter J. Sterk, M.D., Ph.D., Lung Function Laboratory, C2-P, Leiden University Medical Center, P.O. Box 9600, NL-2300 RC Leiden, The Netherlands. E-mail: p.j.sterk{at}lumc.nl

Airway inflammation in asthma may represent a favorable environment for respiratory viral infections, augmenting virus-induced exacerbations in asthma. We postulated that repeated low-dose allergen exposure preceding experimental rhinovirus 16 (RV16) infection increases the severity of RV-induced airway obstruction and inflammation. Thirty-six house dust mite–allergic patients with mild to moderate asthma participated in a three-arm, parallel, placebo-controlled, double-blind study. Patients inhaled a low dose of house dust mite allergen for 10 subsequent working days (Days 1–5 and 8–12) and/or were subsequently infected with RV16 (Days 15 and 16). Allergen exposure resulted in a significant fall in FEV1 (p < 0.001) and provocative concentration of histamine causing a 20% fall in FEV1 (p < 0.001) and an increase in exhaled nitric oxide (p < 0.001) and percentage of sputum eosinophils (p < 0.001). RV16 infection led to a fall in FEV1 (p = 0.02) and increases in the percentage of sputum neutrophils (p = 0.01), sputum interleukin-8 (p = 0.04), and neutrophil elastase (p = 0.04). Successive allergen exposure and RV16 infection had no synergistic or additive effect on any of the clinical or inflammatory outcomes. In conclusion, repeated low-dose allergen exposure and RV16 infection induce distinct inflammatory profiles within the airways in asthma without apparent interaction between these two environmental triggers. This suggests that preceding allergen exposure, at the used dose and duration, is not a determinant of the severity of RV-induced exacerbations in patients with mild to moderate asthma.

Key Words: asthma exacerbation • airway hyperresponsiveness • inflammation • sputum • nasal lavage fluid




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
M. A. Schaller, L. E. Kallal, and N. W. Lukacs
A Key Role for CC Chemokine Receptor 1 in T-Cell-Mediated Respiratory Inflammation
Am. J. Pathol., February 1, 2008; 172(2): 386 - 394.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
D. Proud and C.-W. Chow
Role of Viral Infections in Asthma and Chronic Obstructive Pulmonary Disease
Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 513 - 518.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
E. Hartmann, H. Graefe, A. Hopert, R. Pries, S. Rothenfusser, H. Poeck, B. Mack, S. Endres, G. Hartmann, and B. Wollenberg
Analysis of Plasmacytoid and Myeloid Dendritic Cells in Nasal Epithelium
Clin. Vaccine Immunol., November 1, 2006; 13(11): 1278 - 1286.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P A B Wark and P G Gibson
Asthma exacerbations {middle dot} 3: Pathogenesis.
Thorax, October 1, 2006; 61(10): 909 - 915.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. Ihre, P. Gyllfors, L. E. Gustafsson, M. Kumlin, and B. Dahlen
Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge
Eur. Respir. J., June 1, 2006; 27(6): 1152 - 1159.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
C S Murray, G Poletti, T Kebadze, J Morris, A Woodcock, S L Johnston, and A Custovic
Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children
Thorax, May 1, 2006; 61(5): 376 - 382.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Bush
Update in pediatrics 2005.
Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 585 - 592.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 265 - 276.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. L. Johnston
Experimental Models of Rhinovirus-induced Exacerbations of Asthma: Where to Now?
Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1145 - 1146.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society